Business
Sernova to Present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
(TheNewswire) LONDON, ON - TheNewswire – November 16...
About this update from Sernova Biotherapeutics Inc
[{"type":"text","content":"Sernova to Present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum\n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n \n LONDON, ON -\n \n \n \n \n TheNewswire\n \n \n \n \n – November 16\n \n \n \n \n ,\n2021\n \n \n \n --\n \n \n Sernova\nCorp\n \n \n .\n \n \n (TSXV:SVA)(FSE/XETRA:PSH)(OTC:SEOVF),\n \n \n a\nleading clinical-stage company focused on regenerative medicine\ntherapeutics, today announced that Dr. Philip Toleikis, President and\nCEO, will present at the Canaccord Genuity Virtual MedTech,\nDiagnostics and Digital Health & Services Forum on Thursday,\nNovember 18\n \n \n th\n \n \n , 2021 at 10:00am ET.\n \n \n \n \n Management will be available throughout the conference\nfor virtual one-on-one meetings. Investors interested in arranging a\nmeeting with the Company’s management during the conference should\ncontact the Canaccord Genuity conference coordinator or Sernova\ninvestor relations.\n \n \n \n \n Webcast Information:\n \n \n \n \n A live webcast of Sernova’s presentation session will\nbe available under ‘Featured News’ on the Company’s website\nat\n \n \n \n \n https://www.sernova.com/press\n \n \n \n \n or by accessing the event directly at following link:\n \n \n \n \n https://wsw.com/webcast/canaccord61/sva.v/2570694\n \n \n \n \n .\n \n \n \n \n ABOUT\n \n \n SERNOVA\n \n \n \n \n \n \n Sernova is developing regenerative medicine therapeutic technologies\nusing an implantable medical device and immune protected therapeutic\ncells (i.e. human donor cells, corrected human cells and stem\ncell-derived cells) to improve the treatment and quality of life of\npeople with chronic metabolic diseases such as insulin-dependent\ndiabetes, blood disorders including hemophilia, and other diseases\ntreated through replacement of proteins or hormones missing or in\nshort supply within the body. For more information, please visit\n \n \n \n \n www.sernova.com\n \n \n \n \n .\n \n \n \n \n \n \n FOR\n \n \n FURTHER\n \n \n INFORMATION,\n \n \n PLEASE\n \n \n CONTACT:\n \n \n \n \n \n \n Investors:\n \n \n \n \n \n \n Corey Davis, Ph.D.\n \n \n \n \n \n \n LifeScience Advisors, LLC\n \n \n \n \n \n \n \n \n [email protected]\n \n \n \n \n \n \n \n \n 212-915-2577\n \n \n \n \n \n \n Corporate:\n \n \n \n \n \n \n Sernova Corp.\n...